Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland

A total of 368 Gram-positive cocci from ABSSI were included in the study. S. aureus and S. pyogenes were susceptible to dalbavancin with MIC50 0.016 mg/L and MIC90 0.032 mg/L for MSSA and MIC50 0.032 mg/L and MIC90 0.047 mg/L for MRSA; MICs for S. pyogenes were ≤0.002–0.008 mg/L; for E. faecalis and...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic microbiology and infectious disease 2019-12, Vol.95 (4), p.114881-114881, Article 114881
Main Authors: Stefaniuk, Elżbieta M., Dudek, Monika, Hryniewicz, Waleria
Format: Article
Language:English
Subjects:
Acute bacterial skin and soft tissue infections (ABSSI)
Anti-Bacterial Agents - pharmacology
Dalbavancin
Enterococci VanA and VanB
Epidemiological Monitoring
Gram-Positive Cocci - drug effects
Gram-Positive Cocci - isolation & purification
Humans
Methicillin-resistant Staphylococcus aureus (MRSA)
Methicillin-sensitive Staphylococcus aureus (MSSA)
Microbial Sensitivity Tests
Poland - epidemiology
Soft Tissue Infections - epidemiology
Soft Tissue Infections - microbiology
Streptococcus pyogenes
Teicoplanin - analogs & derivatives
Teicoplanin - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3
cites cdi_FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3
container_end_page 114881
container_issue 4
container_start_page 114881
container_title Diagnostic microbiology and infectious disease
container_volume 95
creator Stefaniuk, Elżbieta M.
Dudek, Monika
Hryniewicz, Waleria
description A total of 368 Gram-positive cocci from ABSSI were included in the study. S. aureus and S. pyogenes were susceptible to dalbavancin with MIC50 0.016 mg/L and MIC90 0.032 mg/L for MSSA and MIC50 0.032 mg/L and MIC90 0.047 mg/L for MRSA; MICs for S. pyogenes were ≤0.002–0.008 mg/L; for E. faecalis and E. faecium, ranging 0.016–0.12 mg/L and 0.012–≥32 mg/L, respectively; MICs for VRE were 0.032–0.125 mg/L.
doi_str_mv 10.1016/j.diagmicrobio.2019.114881
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283995992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889319302172</els_id><sourcerecordid>2283995992</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3</originalsourceid><addsrcrecordid>eNqNkDlvGzEQRonARizb-QsBkSrNKjxWWjKd4fgIYMAp4pqY5SGMrF0qnJUA__tQkB2kdDVTvG-Ox9gXKeZSyOW39TwgrAb0JfeY50pIO5eyNUZ-YDNpOtsI0YkTNhOdVo0xVp-xc6K1EFLZVnxkZ1q2XdcKM2PPV37CPU4vPCceYNPDHkaPI4cV4EgTXxUYmm0mrFjkPnuPHClvYIqBp5IHTs8HfAyccpr4hES7yHFMsU7OI9WW_6r8GC7ZaYINxU-v9YI93d78vr5vHh7vfl5fPTReGzE1KiYwulf9MiizMFpLWCgtjFTKe4Cw6JceOu1bbUEsoQMA0dqkQ0rSQAJ9wb4e525L_rOLNLkBycdNvSHmHTmljLZ2Ya2q6PcjWl0SlZjctuAA5cVJ4Q6y3dr9L9sdZLuj7Br-_Lpn1w8x_Iu-2a3AjyMQ67d7jMWRxzj6GLBUOy5kfM-ev3DImV0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2283995992</pqid></control><display><type>article</type><title>Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland</title><source>Elsevier</source><creator>Stefaniuk, Elżbieta M. ; Dudek, Monika ; Hryniewicz, Waleria</creator><creatorcontrib>Stefaniuk, Elżbieta M. ; Dudek, Monika ; Hryniewicz, Waleria</creatorcontrib><description>A total of 368 Gram-positive cocci from ABSSI were included in the study. S. aureus and S. pyogenes were susceptible to dalbavancin with MIC50 0.016 mg/L and MIC90 0.032 mg/L for MSSA and MIC50 0.032 mg/L and MIC90 0.047 mg/L for MRSA; MICs for S. pyogenes were ≤0.002–0.008 mg/L; for E. faecalis and E. faecium, ranging 0.016–0.12 mg/L and 0.012–≥32 mg/L, respectively; MICs for VRE were 0.032–0.125 mg/L.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/j.diagmicrobio.2019.114881</identifier><identifier>PMID: 31477408</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute bacterial skin and soft tissue infections (ABSSI) ; Anti-Bacterial Agents - pharmacology ; Dalbavancin ; Enterococci VanA and VanB ; Epidemiological Monitoring ; Gram-Positive Cocci - drug effects ; Gram-Positive Cocci - isolation &amp; purification ; Humans ; Methicillin-resistant Staphylococcus aureus (MRSA) ; Methicillin-sensitive Staphylococcus aureus (MSSA) ; Microbial Sensitivity Tests ; Poland - epidemiology ; Soft Tissue Infections - epidemiology ; Soft Tissue Infections - microbiology ; Streptococcus pyogenes ; Teicoplanin - analogs &amp; derivatives ; Teicoplanin - pharmacology</subject><ispartof>Diagnostic microbiology and infectious disease, 2019-12, Vol.95 (4), p.114881-114881, Article 114881</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3</citedby><cites>FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31477408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stefaniuk, Elżbieta M.</creatorcontrib><creatorcontrib>Dudek, Monika</creatorcontrib><creatorcontrib>Hryniewicz, Waleria</creatorcontrib><title>Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>A total of 368 Gram-positive cocci from ABSSI were included in the study. S. aureus and S. pyogenes were susceptible to dalbavancin with MIC50 0.016 mg/L and MIC90 0.032 mg/L for MSSA and MIC50 0.032 mg/L and MIC90 0.047 mg/L for MRSA; MICs for S. pyogenes were ≤0.002–0.008 mg/L; for E. faecalis and E. faecium, ranging 0.016–0.12 mg/L and 0.012–≥32 mg/L, respectively; MICs for VRE were 0.032–0.125 mg/L.</description><subject>Acute bacterial skin and soft tissue infections (ABSSI)</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Dalbavancin</subject><subject>Enterococci VanA and VanB</subject><subject>Epidemiological Monitoring</subject><subject>Gram-Positive Cocci - drug effects</subject><subject>Gram-Positive Cocci - isolation &amp; purification</subject><subject>Humans</subject><subject>Methicillin-resistant Staphylococcus aureus (MRSA)</subject><subject>Methicillin-sensitive Staphylococcus aureus (MSSA)</subject><subject>Microbial Sensitivity Tests</subject><subject>Poland - epidemiology</subject><subject>Soft Tissue Infections - epidemiology</subject><subject>Soft Tissue Infections - microbiology</subject><subject>Streptococcus pyogenes</subject><subject>Teicoplanin - analogs &amp; derivatives</subject><subject>Teicoplanin - pharmacology</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqNkDlvGzEQRonARizb-QsBkSrNKjxWWjKd4fgIYMAp4pqY5SGMrF0qnJUA__tQkB2kdDVTvG-Ox9gXKeZSyOW39TwgrAb0JfeY50pIO5eyNUZ-YDNpOtsI0YkTNhOdVo0xVp-xc6K1EFLZVnxkZ1q2XdcKM2PPV37CPU4vPCceYNPDHkaPI4cV4EgTXxUYmm0mrFjkPnuPHClvYIqBp5IHTs8HfAyccpr4hES7yHFMsU7OI9WW_6r8GC7ZaYINxU-v9YI93d78vr5vHh7vfl5fPTReGzE1KiYwulf9MiizMFpLWCgtjFTKe4Cw6JceOu1bbUEsoQMA0dqkQ0rSQAJ9wb4e525L_rOLNLkBycdNvSHmHTmljLZ2Ya2q6PcjWl0SlZjctuAA5cVJ4Q6y3dr9L9sdZLuj7Br-_Lpn1w8x_Iu-2a3AjyMQ67d7jMWRxzj6GLBUOy5kfM-ev3DImV0</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Stefaniuk, Elżbieta M.</creator><creator>Dudek, Monika</creator><creator>Hryniewicz, Waleria</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201912</creationdate><title>Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland</title><author>Stefaniuk, Elżbieta M. ; Dudek, Monika ; Hryniewicz, Waleria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute bacterial skin and soft tissue infections (ABSSI)</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Dalbavancin</topic><topic>Enterococci VanA and VanB</topic><topic>Epidemiological Monitoring</topic><topic>Gram-Positive Cocci - drug effects</topic><topic>Gram-Positive Cocci - isolation &amp; purification</topic><topic>Humans</topic><topic>Methicillin-resistant Staphylococcus aureus (MRSA)</topic><topic>Methicillin-sensitive Staphylococcus aureus (MSSA)</topic><topic>Microbial Sensitivity Tests</topic><topic>Poland - epidemiology</topic><topic>Soft Tissue Infections - epidemiology</topic><topic>Soft Tissue Infections - microbiology</topic><topic>Streptococcus pyogenes</topic><topic>Teicoplanin - analogs &amp; derivatives</topic><topic>Teicoplanin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stefaniuk, Elżbieta M.</creatorcontrib><creatorcontrib>Dudek, Monika</creatorcontrib><creatorcontrib>Hryniewicz, Waleria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stefaniuk, Elżbieta M.</au><au>Dudek, Monika</au><au>Hryniewicz, Waleria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>2019-12</date><risdate>2019</risdate><volume>95</volume><issue>4</issue><spage>114881</spage><epage>114881</epage><pages>114881-114881</pages><artnum>114881</artnum><issn>0732-8893</issn><eissn>1879-0070</eissn><abstract>A total of 368 Gram-positive cocci from ABSSI were included in the study. S. aureus and S. pyogenes were susceptible to dalbavancin with MIC50 0.016 mg/L and MIC90 0.032 mg/L for MSSA and MIC50 0.032 mg/L and MIC90 0.047 mg/L for MRSA; MICs for S. pyogenes were ≤0.002–0.008 mg/L; for E. faecalis and E. faecium, ranging 0.016–0.12 mg/L and 0.012–≥32 mg/L, respectively; MICs for VRE were 0.032–0.125 mg/L.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31477408</pmid><doi>10.1016/j.diagmicrobio.2019.114881</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-8893
ispartof Diagnostic microbiology and infectious disease, 2019-12, Vol.95 (4), p.114881-114881, Article 114881
issn 0732-8893
1879-0070
language eng
recordid cdi_proquest_miscellaneous_2283995992
source Elsevier
subjects Acute bacterial skin and soft tissue infections (ABSSI)
Anti-Bacterial Agents - pharmacology
Dalbavancin
Enterococci VanA and VanB
Epidemiological Monitoring
Gram-Positive Cocci - drug effects
Gram-Positive Cocci - isolation & purification
Humans
Methicillin-resistant Staphylococcus aureus (MRSA)
Methicillin-sensitive Staphylococcus aureus (MSSA)
Microbial Sensitivity Tests
Poland - epidemiology
Soft Tissue Infections - epidemiology
Soft Tissue Infections - microbiology
Streptococcus pyogenes
Teicoplanin - analogs & derivatives
Teicoplanin - pharmacology
title Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activity%20of%20dalbavancin%20against%20gram-positive%20cocci%20isolated%20from%20skin%20and%20soft%20tissue%20infections%20in%20Poland&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=Stefaniuk,%20El%C5%BCbieta%20M.&rft.date=2019-12&rft.volume=95&rft.issue=4&rft.spage=114881&rft.epage=114881&rft.pages=114881-114881&rft.artnum=114881&rft.issn=0732-8893&rft.eissn=1879-0070&rft_id=info:doi/10.1016/j.diagmicrobio.2019.114881&rft_dat=%3Cproquest_cross%3E2283995992%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c380t-2efa83b2b6d2858331a52308122ccaad5b6ca73c439a06a7aaa049f3dff18afa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2283995992&rft_id=info:pmid/31477408&rfr_iscdi=true